Minerva Neurosciences Inc (NERV) is up 5.98% Friday In Premarket Trading

Minerva Neurosciences Inc (NERV) has risen Friday morning, with the stock climbing 5.98% in pre-market trading to 1.95. NERV's short-term technical score of 25 indicates that the stock has traded less bullishly over the last month than 75% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, Minerva Neurosciences Inc ranks higher than 53% of stocks. Minerva Neurosciences Inc has fallen 5.64% over the past month, closing at $1.89 on August 27. During this period of time, the stock fell as low as $1.67 and as high as $1.95. NERV has an average analyst recommendation of Buy. The company has an average price target of $6.50.

NERV has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on NERV!

See Full NERV Report

Minerva Neurosciences Inc has a Long-Term Technical rank of 5. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 95% of the market scoring higher. In the Biotechnology industry which is number 130 by this metric, NERV ranks better than 11% of stocks.

Important Dates for Investors in NERV:

-Minerva Neurosciences Inc is set to release earnings on 10/31/2021. During their last earnings release the company posted EPS of $-0.83. -We do not have a set dividend date for Minerva Neurosciences Inc at this time. Click Here To Get The Full Report on Minerva Neurosciences Inc (NERV)